Results 151 to 160 of about 25,062 (184)

Invasive neonatal candidiasis: an overview

Seminars in Perinatology, 2003
Until the 1980s, recovery of Candida species from normally sterile body sites in high-risk infants was often dismissed as contamination. Such delay in diagnosis often resulted in death, multifocal disease, or significant morbidity, outcomes that still occur today.
Rachel L, Chapman, Roger G, Faix
openaire   +2 more sources

Invasive Candidiasis During Granulocytopenia

1993
Candidiasis remains the most frequently encountered fungal infection in patients with profound granulocytopenia and appears to be increasing in frequency. In addition, Candida infections are occurring earlier during remission induction chemotherapy and can be caused by a variety of species such as C. albicans, C. tropicalis, and C. krusei.
E, Anaissie, H, Pinczowski
openaire   +2 more sources

The Role of the Laboratory in the Diagnosis of Invasive Candidiasis

Drugs, 2009
A diagnosis of invasive candidiasis can be achieved using conventional approaches (microscopy, culture, serology), as well as new methods, including antigen detection and polymerase chain reaction (PCR) assays. Most of the conventional approaches lack sensitivity, especially for obtaining a diagnosis of invasive candidiasis in immunocompromised ...
M. T. Montagna, R. Iatta, E. Borghi, G. Morace   +3 more
openaire   +4 more sources

Invasive candidiasis in neonates and children

Early Human Development, 2011
Invasive candidiasis is associated with high morbidity and mortality in neonates and children. The incidence of invasive candidiasis is greater in children than in adults and is particularly high in neonates. Main risk factors are multiple antibiotics, central venous catheters, parenteral nutrition, immunodepression, low birth weight, fungal ...
openaire   +2 more sources

Rezafungin: A Review in Invasive Candidiasis

Drugs
Rezafungin (Rezzayo®) is a next-generation echinocandin antifungal with improved pharmacokinetic properties over first-generation echinocandins that allows for once-weekly rather than once-daily intravenous administration. It has recently been approved for the treatment of adults with invasive candidiasis in the EU and UK, and is approved for adults ...
Simon Fung, Matt Shirley
openaire   +2 more sources

Invasive Candidiasis in Asia

2019
This chapter provides an overview on the epidemiology of invasive candidiasis in Asia highlighting the unique features of Candida tropicalis, a common Candida species of particular importance in Asia, and Candida auris, a recently emerging multidrug-resistant Candida species, which was first reported from Asia and has caused public health impact ...
openaire   +1 more source

Serodiagnosis of Invasive Candidiasis

Annals of the New York Academy of Sciences, 1988
L S, Young, P R, Stevens
openaire   +2 more sources

Neonatal invasive candidiasis.

Minerva pediatrica, 2007
Over the last two decades, systemic fungal infections have emerged to play a primary role in hospital-acquired infections. C. albicans is involved in 75% of neonatal candidiasis; however, the incidence of infection from C. parapsilosis is also increasing significantly. The higher incidence observed in the high-risk group of very low birth weight (VLBW)
M, Stronati, L, Decembrino
openaire   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
William Oh, Matthew Galsky, Vaibhav Patel   +2 more
exaly  

Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma

Ca-A Cancer Journal for Clinicians, 2002
Mónica Morrow, D D Dershaw, S Eva Singletary   +2 more
exaly